A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
CLL Profile : 1016115
Test CodeMDFCPCLLPRO or 1016115
Alias/See Also
Chronic Lymphocytic Leukemia; CLL; BIRC3; BTK; MYD88; NOTCH1; PLCG2; SF3B1; TP53; TP53 and ATM deletion; 6q deletion; trisomy 12 and 13q deletion; IGH(14q32.3); IGH/CCND1 t(11;14); IGH/BCL2 t(14;18)
CPT Codes
81450, 88271x11, 88275x5
Includes
Includes: Molecular: BIRC3, BTK, MYD88, NOTCH1, PLCG2, SF3B1, TP53
Cytogenetic: Trisomy 12, 13q deletion, TP53 (17p13) deletion, ATM (11q22.3) deletion, 6q deletion, IGH (14q32.3) rearrangement, IGH/CCND1 t(11;14) translocation, reflex to IGH/BCL2 t(14;18) translocation probe will be performed at an additional charge (CPT code(s): 88271x2, 88275).
Cytogenetic: Trisomy 12, 13q deletion, TP53 (17p13) deletion, ATM (11q22.3) deletion, 6q deletion, IGH (14q32.3) rearrangement, IGH/CCND1 t(11;14) translocation, reflex to IGH/BCL2 t(14;18) translocation probe will be performed at an additional charge (CPT code(s): 88271x2, 88275).
Instructions
Peripheral Blood in a lavender top (EDTA) tube and/or a green top sodium heparin tube.
OR
Bone Marrow in a lavender top (EDTA) tube and/or a green top sodium heparin tube.
OR
Bone Marrow in a lavender top (EDTA) tube and/or a green top sodium heparin tube.
Transport Container
Submit 5-10 mL Blood in a lavender top and/or 5-10 mL Blood in a green top.
OR
Submit 2-3 mL Bone Marrow in a lavender top and/or 2-3 mL Bone Marrow in a green top.
Do not centrifuge.
OR
Submit 2-3 mL Bone Marrow in a lavender top and/or 2-3 mL Bone Marrow in a green top.
Do not centrifuge.
Transport Temperature
Refrigerated.
Specimen Stability
Ambient: 48 hours; Refrigerated: 15 days; Frozen: Unacceptable
Methodology
Next Generation Sequencing and Fluorescence in situ hybridization (FISH)
Setup Schedule
Monday & Thursday
Report Available
8-10 days
Reference Range
An integrated report with results from all tests along with relevant diagnostic, prognostic and clinical trial information.
Clinical Significance
Helps physicians diagnose and predict the course of disease progression for hematologic diseases.
Performing Laboratory
med fusion